Lead Product(s) : Fibrinogen
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
FDA Approvals Strengthen Octapharma USA Pediatric Critical Care Product Portfolio
Details : The supplement approvals resulted in new product labeling for Octaplas™, Pooled Plasma (Human), Solvent/Detergent (S/D) Treated Solution for Intravenous Infusion, and fibryga®, Fibrinogen (Human) Lyophilized Powder for Reconstitution.
Product Name : Fibryga
Product Type : Protein
Upfront Cash : Inapplicable
March 29, 2021
Lead Product(s) : Fibrinogen
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable